Multiplex Assays : Expanding End User Industry Helping The Global Market Growth


Posted November 11, 2019 by HealthcareNews

The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%.
 
What are the Global Growth Factors?

The major factors driving the growth of the Multiplex Assays Market include the adoption of companion diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays.

What The Experts Says about the Market Growth?

The global multiplex assays market is projected to reach $3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%.

Browse and in-depth TOC on "Multiplex Assays Market"
109 – Tables
32 - Figures
142 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314

Based on product and service, the consumables segment is accounted for the largest share of the market in 2018

On the basis of product & service, the market is broadly segmented into instruments, consumables, and software & services. In 2018, the consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.

Based on technology, flow cytometry segment is expected to grow at the highest CAGR in the market during the forecast period

On the basis of technology, the global multiplex assays market is divided into flow cytometry, multiplex RT PCR, luminescence, fluorescence detection, and other technologies. In 2018, the flow cytometry segment is expected to grow at the highest CAGR in the global multiplex assays industry. The high CAGR can be attributed to the wide applications of flow cytometry in detection & measurement of protein expression, RNA, cell health status (cell viability & toxicity), and characterization & identification of various cell types.

Geographical Analysis:

North America is expected to account for the largest share of the global multiplex assays market. Asia is expected to register the highest growth rate from 2018 to 2023. This can be attributed to its pharmaceutical market which is growing at the fastest pace in the world, the availability of a large number of qualified researchers, and increasing prevalence of cancer and infectious diseases.

Get Expert Analysis and Insights of Global Market | Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=61593314

Key Market Players:

The key players in the global multiplex assays market include Luminex (US), Bio-Rad Laboratories (US), Becton, Dickinson (US), Illumina (US), and Thermo Fisher Scientific (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Biotech News
Phone 18886006441
Business Address USA
Country United States
Categories Biotech , Business , Marketing
Tags biotechnology , multiplex assays , multiplex assays market
Last Updated November 11, 2019